IngredientesRed root is a shrub also known as wild snowball for its clusters of white flowers borne in early summer. Its standardized common name is red root, and its botanical name is Ceanothus americanus L., belonging to the plant family Rhamnaceae. Additional common names include Red-root, New Jersey tea, and Wild snowball. Further common names used for the plant include Redshank, Mountain Lilac, Buckbrush, Snow Brush, and Desert Buckthorn.
It is important to note that the common name "red root" is sometimes applied loosely to more than one species. New Jersey Tea is generally used to describe C. americanus, or C. herbaceus, and is less used when describing the Ceanothus species of the West Coast, though the species C. sanguineus is sometimes called "Oregon Tea." The present article focuses primarily on C. americanus, which is the species most thoroughly documented in medical and herbal literature.
Red root should not be confused with bloodroot (Sanguinaria canadensis). Red root is Ceanothus americanus, while bloodroot is Sanguinaria canadensis — different plant families, different actions, different safety profiles. Bloodroot is a powerful and potentially toxic escharotic herb used externally in very specific cases.
The plant has a large root with a red or brown epidermis, containing many small white veins, with the body of the root being dark-red. The stems are from 2 to 4 feet high, slender, with many reddish, round, smooth branches. The leaves are ovate or oblong-ovate, acuminate, serrate, 3-veined, rather smooth above, downy with soft reddish hairs beneath, and often heart-shaped at the base. The flowers are minute, white, in long, crowded panicles from the axils of the upper leaves.
Ceanothus americanus is indigenous to the United States, and is very abundant in the West; it grows in dry woodlands, barrens, etc., flowering from June to August. The species is also found in Canada, in Ontario and Quebec. In the U.S., it is found across a wide range of states including Alabama, Arkansas, Connecticut, Delaware, Florida, Georgia, Illinois, Indiana, Iowa, Kansas, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, New Hampshire, New Jersey, New York, North and South Carolina, Ohio, Oklahoma, Pennsylvania, Rhode Island, Texas, Vermont, West Virginia, Wisconsin, and Virginia.
The parts used are the root or inner bark of the root. The leaves are astringent and slightly bitter, and have been used as a substitute for tea; the root is the medicinal part, and has a taste and smell somewhat resembling those of the peach leaf. Typical preparations include teas, tinctures, and capsule form.
The root is prepared by various methods depending on the tradition or practitioner. Water extracts the active principle, making decoctions a natural preparation. As a decoction, the standard preparation is 1 tsp per cup, taken as 1 cup three times daily (TID); as a tincture (1:5, 45% ethanol), a typical dose is 2–3 ml TID. Liquid extract dosage has also been recorded as 15–40 mL/week at a 1:2 preparation.
Herbalists have used the root and root bark for its astringent, expectorant, and sedative qualities for centuries. Red root was initially brought into wider medical awareness through the Native Americans who used it for a wide variety of ailments. The red roots and root bark were used by Native Americans in North America for infections of the upper respiratory tract. They also used the roots in washes for syphilis and cancer, and other parts of the plant for treating dysentery, gonorrhea, and eye problems in children.
Red root has a long history of use in traditional Native American medicine. People brewed the root as a tea and used it to treat colds, fever, pneumonia, digestive problems, toothaches, and urinary tract infections in women. It was often used as a febrifuge to reduce fever. The plant was believed to have properties that could help cool the body during periods of illness associated with high fever. Some tribes also used it as a digestive aid, preparing infusions or decoctions from the plant to soothe stomach ailments. It was also used topically in poultices to treat skin conditions like rashes and minor wounds.
The dried leaves, slightly bitter and astringent, acquired considerable notoriety during the War of American Independence as a substitute for black tea. The leaves, flowers, and root were used medicinally, and reputed astringent, diuretic, tonic, expectorant, sedative, antispasmodic, and antisyphilitic. The Indians used it in fevers, dysentery, epilepsy, and asthma and chronic bronchial conditions.
The plant is commonly called New Jersey tea because during the Revolutionary War, American colonists used the leaves of the plant as a substitute for tea. The use of Ceanothus americanus to treat a wide variety of ailments including blood coagulation and pressure, spleen pain, and even cancer has been supported by its rich history in folk medicine. It has been used as a tea substitute during the American Revolutionary and Civil War.
King's American Dispensatory is a 19th-century medical and botanical textbook, first published in 1854, that covers the uses of herbs used in American medical practice, especially by those involved in eclectic medicine — the botanical school of medicine in the 19th and 20th centuries. Red root was prominently featured in this tradition. Specific indications and uses noted in the Eclectic tradition included enlarged spleen, sallow doughy skin, an expressionless countenance, non-inflammatory catarrhal states, and profuse secretion.
The 19th-century homeopathic literature also recorded an association with the spleen. In that tradition, Ceanothus was described as "a spleen remedy par excellence," with symptoms of deep-seated pain in the left hypochondrium, pain and fullness in the left side. In the 19th century, the plant became popular among herbalists for treating dysentery, liver problems, and anemia.
The 1869 Physiomedical Dispensatory of William Cook recorded a more cautious assessment: the root of this plant is medicinal, but is not very powerful or reliable. It is a mild stimulating astringent with slight tonic qualities, and reported to be nervine and expectorant. Cook further noted: it is spoken of in syphilis, asthma, and bronchitis but is of doubtful efficacy in these cases, though a good alterant for milder cases. A decoction was made with an ounce of the root in a pint of boiling water, of which one to two fluid ounces might be given two or three times a day.
In homeopathy, Ceanothus americanus acquired a distinct clinical reputation as a remedy for the spleen, particularly following malarial or other chronic febrile illness. Traditional American sources describe a marked astringent action due to tannin content, aligning with clinical uses in diarrhœa and mucous membrane relaxation; Eclectic practitioners and early homeopaths repeatedly associated the remedy with spleen enlargement and tenderness, particularly left hypochondrium pain with "ague cake" after intermittent fevers. The homeopathic use of Ceanothus americanus is not supported by the kind of evidence-based clinical trial data required by modern regulatory bodies. The FDA is not aware of scientific evidence to support homeopathy as effective.
The most chemically distinctive constituents of red root are its cyclopeptide alkaloids. These include ceanothine and americine (cyclopeptide alkaloids), which are thought to support lymphatic drainage and immune health. A 2018 study reported the first total synthesis of the reported structure of ceanothine D, one of the cyclopeptide alkaloids isolated from the plant. The structural similarity of cyclopeptide alkaloids from this plant is categorized by the size of the macrocycle, which can be 13-, 14-, or 15-membered. Isolation and extraction from Ceanothus americanus is non-trivial, since extraction methods suffer from low yields of complex mixtures.
A landmark phytochemical study published in Phytochemistry (1997) identified several triterpene constituents using bioassay-guided fractionation. Through bioassay-guided fractionation and purification, three triterpenes — ceanothic acid, 27-hydroxy ceanothic acid, and ceanothetric acid — and two flavonoids (maesopsin and maesopsin-6-O-glucoside) were identified; ceanothetric acid and maesopsin-6-O-glucoside were new compounds at the time. The triterpene acids ceanothic acid and ceanothetric acid are considered anti-inflammatory and supportive of tissue repair.
Betulinic acid, a lupane-type pentacyclic triterpene also present in the Ceanothus genus, has attracted extensive independent pharmacological research. Betulinic acid is a naturally occurring pentacyclic lupane-type triterpenoid usually isolated from birch trees, but present in many other botanical sources; it is found in different plant organs, both as a free aglycon and as glycosyl derivatives. A wide range of pharmacological activities has been described for this triterpenoid, including antiviral and antitumor effects. In addition, several other interesting properties have been identified in the fields of immunity and metabolism, namely antidiabetic, antihyperlipidemic, and anti-inflammatory activities.
The root contains tannins at approximately 10% concentration, along with resin, bitter components, and gum. Tannins are a type of polyphenol antioxidant. They help protect cells and DNA from oxidative damage. Lab and animal studies suggest tannins may protect the heart and blood vessels, as well as reduce blood pressure and blood sugar levels. They can also prevent the growth of some types of bacteria and other microbes.
Flavonoids identified in C. americanus include maesopsin and maesopsin-6-O-glucoside (which are attributed with antioxidant and circulatory support properties), as well as phenolic acids such as chlorogenic acid and caffeic acid (associated with antioxidant and detoxifying functions). Saponins are also present and are considered to aid in nutrient absorption and immune function.
Identification and evaluation of the blood coagulating principles from the root bark of Ceanothus americanus has been investigated. An acidic fraction was prepared by an ion exchange resin method. The acidic constituents identified by paper chromatographic techniques were four dicarboxylic and two phosphoric acids. All of these acids possessed a diphasic blood coagulating action as determined by an electrical conductivity method using the blood of calcium-treated rats.
Ceanothus americanus has hemostatic properties attributed to its alkaloids, which interact with antithrombin and thromboplastin in the blood coagulation pathway. The exact mechanism has not been precisely determined, but it is believed that several alkaloids in the root bark tincture trigger blood coagulation. Flavonoid compounds in C. americanus may increase the expression of immune-related genes such as tumor necrosis factor (TNF)-α, which in turn activates platelet aggregation, thereby reducing clotting time. Tannins present in the plant extract precipitate blood proteins, leading to the synthesis of thromboxane A2 and recruitment of additional platelets to form platelet aggregation at the site of damaged vessels.
An important nuance regarding dose-dependence was noted in a pharmacological study: at low concentrations, the active fraction of Ceanothus (termed "Ceanothyn") acted as a coagulant, while increasing the concentration caused it to become an anticoagulant.
During the search for antimicrobial compounds from higher plant sources, a methanol extract of Ceanothus americanus demonstrated antimicrobial activity against selected oral pathogens. Ceanothic acid and ceanothetric acid demonstrated growth inhibitory effects against Streptococcus mutans, Actinomyces viscosus, Porphyromonas gingivalis, and Prevotella intermedia with MICs ranging from 42 to 625 micrograms/mL. Maesopsin, its glucoside, and 27-hydroxy ceanothic acid were inactive below a concentration of 500 micrograms/mL.
Betulinic acid (BA), one of the triterpenes present in red root, has broad-spectrum anti-inflammatory activity, significantly increasing IL-10 production, decreasing ICAM-1, VCAM-1, and E-selectin expression, and inhibiting nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB). Betulinic acid is a potential lead compound for the development of new anti-inflammatory treatments, and a large number of derivatives have been produced and tested. The potential of betulinic acid and its derivatives has been shown in a number of pre-clinical studies using different experimental models. Several molecular mechanisms of action have also been described. These findings, however, are specific to betulinic acid studied in isolation and have not been replicated in whole-extract C. americanus clinical studies.
Key chemical constituents include tannins, alkaloids (e.g., ceanothine), flavonoids, and saponins. Tannins contribute to its astringent properties, while alkaloids are linked to its effects on the circulatory and lymphatic systems.
The strongest area of direct in vitro evidence for C. americanus is antimicrobial activity against oral pathogens. Through bioassay-guided fractionation, ceanothic acid and ceanothetric acid were identified and demonstrated growth inhibitory effects against Streptococcus mutans, Actinomyces viscosus, Porphyromonas gingivalis, and Prevotella intermedia with MICs ranging from 42 to 625 micrograms/mL; ceanothetric acid was at that time a newly identified compound. This evidence is entirely in vitro (laboratory-based); no human clinical trials have tested red root for the treatment of oral infections.
The blood coagulation activity of C. americanus has been examined in animal studies. Oral administration of 3.5–7.0 mL of the acidic fraction (Ceanothyn) decreased blood coagulation time for a period of approximately 1 hour, with accelerated clotting noted within 10 to 20 minutes after administration. Repeated oral doses of Ceanothyn kept the blood coagulation time diminished. Dialysed Ceanothyn reduced clotting time when added to whole blood, indicating that the active fraction was of small molecular size. This research was conducted using calcium-treated rat blood and represents animal-level evidence only; no controlled human clinical trials on coagulation have been published.
A 2023 computational analysis examined which compounds from C. americanus have the highest predicted blood coagulant potential using molecular docking and ADMET (absorption, distribution, metabolism, excretion, toxicity) modeling. In this study, computational analyses were employed to identify the compounds of C. americanus with blood coagulant potential using physicochemical and pharmacokinetic servers and molecular docking techniques. This is a preprint-level computational study; results have not been validated in clinical trials.
Betulinic acid, present in red root, has generated substantial preclinical research interest as an anticancer agent. Betulinic acid has demonstrated selective cytotoxicity against a number of specific tumor types, a variety of infectious agents such as HIV, malaria, and bacteria, and the inflammatory process in general. Biological activity was first demonstrated in melanoma cell lines and was confirmed in mice bearing human melanoma xenografts. These in vivo studies also established a favorable safety margin, as systemic side effects were not observed at any dose. Considerable in vitro evidence has demonstrated that betulinic acid is effective against small- and non-small-cell lung, ovarian, cervical, and head and neck carcinomas. Published data suggest that betulinic acid induces apoptosis in sensitive cells in a p53- and CD95-independent fashion.
Betulinic acid shows a wide spectrum of biological and pharmacological properties, such as anti-inflammatory, antibacterial, antiviral, antidiabetic, antimalarial, anti-HIV, and antitumor effects; among them, the antitumor activity of betulinic acid has been extensively studied. Important caveat: this body of research pertains to betulinic acid studied in isolation, typically extracted from birch trees, and does not specifically evaluate C. americanus extracts. There are no registered human clinical trials testing red root extract as an anticancer agent.
The purported lymphagogue (lymph-flow-promoting) and splenotonic effects of red root are among the most prominent claims made by herbalists and naturopathic practitioners, but this area is the least supported by formal clinical evidence. Despite red root's long history, very few scientific studies have analyzed its ability to treat various health conditions. Red root is an herbal preparation made from the root of Ceanothus americanus, traditionally used in Native American and folk medicine for various ailments. Proponents claim red root supports digestive and respiratory health, the lymphatic system, and the spleen, though high-quality human research is lacking.
One secondary source cites a 2010 study of 38 thalassemic patients in which homeopathic Ceanothus reportedly appeared to improve spleen function and reduce splenomegaly; however, this finding involves a homeopathic preparation (highly diluted) rather than herbal-dose extracts, and the primary literature for this study was not retrievable for direct verification. Its evidentiary value for herbal red root preparations cannot therefore be confirmed and should be treated with caution.
An animal study from 1948 examined the influence of a leaf tea from Ceanothus americanus on blood pressure in hypertensive rats. This study, published in Federation Proceedings, investigated the "Influence of tea from leaves of Ceanothus americanus on blood pressure of hypertensive rats" (Wastl H., 1948). No abstract is publicly available, and this work has not been updated or replicated in human clinical trials.
Some in vitro studies have shown that certain components of Ceanothus americanus extracts can induce apoptosis (programmed cell death) in cancer cells — an important mechanism for eliminating cancer cells without causing damage to normal cells. Flavonoids have been shown to disrupt the cell cycle of cancer cells and trigger apoptosis. However, more research is needed in this area.
Despite red root's long history, very few scientific studies have analyzed its ability to treat various health conditions. The current body of evidence consists primarily of: (1) in vitro (cell culture) studies demonstrating antimicrobial activity of isolated triterpenes against oral bacteria; (2) animal studies on blood coagulation using acidic fractions; (3) extensive preclinical research on betulinic acid (a related triterpene) conducted independently of red root itself; and (4) historical and ethnobotanical documentation. No large-scale randomized controlled trials in humans have been published examining any clinical endpoint for Ceanothus americanus as a whole herb or standardized extract.
Red root is widely used in contemporary herbal practice to stimulate the lymphatic system, promoting the removal of toxins and reducing swollen lymph nodes. It is particularly cited in conditions where the body needs support in clearing waste and excess fluids. The mechanism proposed by herbalists — that the cyclopeptide alkaloids gently stimulate lymph flow — has not been formally validated in human clinical trials.
The association between red root and the spleen is one of the oldest and most consistent threads in the plant's recorded history. The Eclectic tradition specifically cited enlarged spleen as a primary indication. In naturopathic practice, the herb is listed as hepatoprotective, hepatorestorative, lymphatic, astringent, antispasmodic, expectorant, and mildly antiseptic. Its use is indicated in splenomegaly and lymphadenopathy, especially pelvic lymphadenopathy.
The root was traditionally used to treat respiratory infections, sore throats, and as a general tonic. Historically it was reputed to be astringent, diuretic, tonic, expectorant, sedative, and antispasmodic.
Medical uses documented in naturopathic literature include use for liver conditions such as fatty liver and hepatitis. No human clinical trial data support these uses.
The in vitro antimicrobial data against oral bacteria (S. mutans, P. gingivalis, and others) provides the closest laboratory correlate to the traditional use of the plant in treating toothache and mouth problems. Some traditions also had people chewing its leaves to soothe throat and mouth irritation.
Decoctions of the root bark and the fresh root have been used to prevent wound bleeding and were found, in animal studies, to be effective in reducing clotting time. The coagulant-active fraction was identified as a set of small-molecule dicarboxylic and phosphoric acids, not the alkaloids or tannins per se.
The following dosages appear in herbal reference and naturopathic literature. They are reported as observed in the sources and do not represent clinical trial–validated dosages.
Long-term safety is unclear due to limited research. No standardized dosage has been established through human clinical trials.
Red root is generally considered safe when used in moderate doses. High doses might cause digestive discomfort due to tannin content. Toxicity is listed as none known in naturopathic literature, though this assessment reflects the absence of reported cases rather than rigorous human safety studies.
Red root is contraindicated during pregnancy and breastfeeding due to limited safety data. This is a general precautionary position reflecting the absence of evidence rather than documented harm.
The most pharmacologically significant safety concern relates to the plant's documented effect on blood coagulation. Red root is considered an effective blood coagulant, and people who are on anticoagulants or who are pregnant should not take this plant medicine. Caution is advised for people with clotting disorders or those on anticoagulant medications, as it may influence coagulation. The demonstrated dose-dependence of the coagulant effect — at low concentrations acting as a coagulant, while increasing concentrations caused it to become an anticoagulant — further complicates predicting interactions with pharmaceutical anticoagulants such as warfarin.
Tannin-rich herbs may reduce the absorption of alkaloids and other basic drugs through precipitation. Due to tannins, red root may reduce the absorption of certain supplements and drugs when taken at the same time. Contraindications noted in naturopathic literature related to tannin content include constipation, iron deficiency, and malnutrition, as dietary tannins are known to inhibit non-heme iron absorption.
The high tannin content (~10%) has a well-characterized general mechanism: tannins chelate iron and can reduce its bioavailability when consumed with food or iron supplements. This is a class effect of tannin-containing plants and is relevant for individuals with iron-deficiency anemia or those relying on dietary iron absorption.
Related species used in herbal practice under the name "red root" include Ceanothus cuneatus, Ceanothus fendleri, and Ceanothus greggii, in addition to C. americanus. Ceanothus reclinatus (Mexico and West Indies) was used by native peoples in gonorrhea, syphilis, dysentery, ulceration of the mouth and fauces, and cancer. The phytochemical composition of these species has not been as thoroughly documented as that of C. americanus, and uses attributed to one Ceanothus species may not be transferable to another.
Condiciones de salud que raíz roja puede ayudar a apoyar.
In vitro studies confirm that Ceanothus species extracts possess significant antioxidant activity attributed to their tannin and flavonoid content. A PMC-indexed laboratory study (PMC3136635) specifically demonstrated remarkable antioxidant activity for Ceanothus coeruleus extracts, and tannin-rich fractions from Ceanothus americanus are characterized as free-radical scavengers. No human antioxidant trials have been conducted.
A published in vitro study (PMID 9276981) specifically demonstrated that Ceanothus americanus extracts inhibit key periodontal pathogens including Porphyromonas gingivalis and Prevotella intermedia. This constitutes direct laboratory evidence for a gum health mechanism. Traditional use as an oral rinse also supports this application. Human clinical trials have not been conducted.
In vitro research directly demonstrates that Ceanothus americanus extracts selectively inhibit key pathogenic oral bacteria — including Streptococcus mutans, Porphyromonas gingivalis, and Prevotella intermedia — without being characterized for effects on beneficial commensal organisms. This provides a direct scientific basis for a relationship with the oral microbial environment. No human studies assessing oral microbiome composition have been conducted.
Anemia is listed as a traditional indication for red root in 19th-century herbal and homeopathic literature, understood through the herb's relationship with the spleen as a blood-filtering and red cell-regulating organ. The most direct evidence is a preliminary human study in thalassemic patients (a hemolytic anemia) that found improvements in hemoglobin-related parameters. Evidence remains very limited.
Ceanothus americanus has been used for asthma in Native American medicine and is specifically listed in Eclectic materia medica (King's American Dispensatory) and Plants for a Future as a traditional remedy for asthmatic conditions. Its antispasmodic and expectorant properties underlie this use. No human clinical trials exist.
Red root's classification as an expectorant, antispasmodic, and mucolytic herb places it in longstanding use for general bronchial conditions including mucus congestion, bronchospasm, and inflammatory airway states. This is recorded in Eclectic, Native American, and modern herbal traditions.
Chronic bronchitis is among the most consistently mentioned traditional indications for Ceanothus americanus, appearing in Native American records, Eclectic materia medica, and contemporary herbalism. The expectorant and antispasmodic actions of the root are cited as the mechanism. No human clinical trials have assessed this use.
Ceanothus americanus has a specific, repeatedly cited traditional use as a topical wash or gargle for canker sores (oral aphthous ulcers) and inflamed oral mucosa associated with fever. This is documented in Eclectic materia medica and early American herbal sources. The astringent tannin content provides a plausible mechanism, but no clinical trials exist.
Red root's anti-inflammatory actions are attributed to its flavonoid and tannin content and are documented in traditional use for chronically inflamed lymphoid, splenic, and hepatic tissue. In vitro evidence supports antioxidant and anti-inflammatory activity of flavonoids from Ceanothus species. No human clinical trials on inflammatory markers have been conducted with Ceanothus americanus.
Colds and fevers are among the oldest documented traditional uses of red root in Native American medicine. Multiple ethnobotanical sources record its use for colds and influenza-like illnesses. The herb's antimicrobial, astringent, and immune-supporting properties form the proposed basis. No controlled clinical trials exist.
Diarrhea and dysentery are traditional indications for red root documented in Native American ethnobotany, Eclectic materia medica, and Clarke's Dictionary of Practical Materia Medica. The high tannin content (approx. 8–10%) provides a well-established astringent mechanism for reducing intestinal hypersecretion. No clinical trials have been conducted.
Fever is one of the oldest and most consistently documented traditional uses of red root, recorded by multiple Native American tribes and referenced in 19th-century materia medica including Clarke's Dictionary. The plant was used as a febrifuge. No modern clinical antipyretic studies have been conducted.
Red root is classified as hepatoprotective and hepatorestorative in naturopathic herbalist monographs, with documented traditional use for liver conditions including fatty liver and hepatitis. 19th-century herbalists and homeopathic materia medica also list liver complaints as an indication. No controlled human trials on hepatic function have been published.
Red root is a component of the well-known Buhner Protocol for Lyme disease and co-infections, used specifically to support lymphatic clearance of Borrelia-related debris and address the splenomegaly associated with tick-borne illness. This use is documented in herbal literature and widely adopted in integrative Lyme care. No controlled clinical trials specifically on red root for Lyme disease have been published.
Red root (Ceanothus americanus) is regarded by herbalists as a primary lymphagogue — a substance that promotes lymph flow and decongests swollen lymph nodes. Its traditional use as a lymphatic herb is well documented in Eclectic and Native American traditions. No controlled human trials specifically on lymphatic drainage have been published. An alkaloid fraction is proposed to stimulate lymphatic movement, but this mechanism has not been verified in clinical research.
Red root is classified as an expectorant and mucolytic in both Eclectic and modern herbal literature, with traditional use for excessive mucus and phlegm in the respiratory tract. Its saponin content is the proposed mucolytic mechanism, and its astringency is used to reduce hypersecretion. No controlled human studies have been published.
Whooping cough (pertussis) is listed as a traditional indication for red root in Native American folk medicine, Eclectic texts (King's American Dispensatory), and early American herbal literature including Jethro Kloss's Back to Eden. The antispasmodic action is the proposed mechanism. No clinical trials exist.
Red root is used by herbalists as a recovery herb following acute illness, on the rationale that lymphatic clearance of dead cells and pathogen debris, and splenic support, accelerate convalescence. This use is articulated in modern herbal sources including Buhner and WishGarden, drawing on traditional lymphatic tonic traditions. No clinical trials have assessed recovery outcomes.
Red root has a documented traditional role in soothing sore throats, applied as a gargle or throat wash. Native Americans used the roots and root bark extensively for sore throat and throat catarrh. Eclectic sources describe it as an astringent wash for inflamed mucous membranes of the throat. No clinical trials have evaluated this use.
Gargling with red root decoction for swollen, inflamed tonsils is a well-documented traditional use appearing in Eclectic and early American herbal texts. Plants for a Future and herbalists such as Jethro Kloss specifically describe it for tonsil swelling. In vitro evidence for antimicrobial activity against relevant oral pathogens provides a plausible mechanism, but no clinical trials exist.
Native American traditions specifically document red root use for catarrh, sore throats, fevers, and mucous membrane problems of the upper respiratory tract. The Eclectic tradition further refined this use for pharyngeal and laryngeal complaints. No human clinical trials on upper respiratory outcomes exist.
Native American women traditionally used red root for urinary tract infections, and urinary complaints appear in Clarke's homeopathic materia medica and homeopathic clinical literature. A mild diuretic action is attributed to its alkaloid content. No modern clinical UTI trials have been conducted.
Native American women traditionally used red root for urinary tract infections, and urinary complaints appear in Clarke's homeopathic materia medica and homeopathic clinical literature. A mild diuretic action is attributed to its alkaloid content. No modern clinical UTI trials have been conducted.
Red root is used in integrative herbal medicine for supporting the immune response during viral illness through lymphatic and splenic stimulation. Native American use for colds, flu, and fevers historically encompasses viral illness. Alkaloids in Ceanothus have demonstrated in vitro antiviral properties as a class; no specific clinical antiviral trials exist for this plant.
Red root has been used in Native American medicine as a topical wash for wounds, sores, and skin infections, documented in multiple ethnobotanical sources. The astringent, haemostatic, and mild antiseptic properties are the proposed mechanisms. No clinical wound-healing studies have been conducted.
Sistemas corporales que raíz roja puede ayudar a apoyar.
Volver